U.S. Exchanges
complete list of health care companies
Comprehensive 2026 directory of publicly traded healthcare stocks on the NYSE and Nasdaq. Track the world's largest pharmaceutical giants, medical device innovators, and health plan providers.
This page is for informational and educational purposes only and does
not constitute investment advice. Always consult a qualified financial
professional before making investment decisions.
Navigating the complete list of health care companies is essential for investors seeking exposure to one of the stock market's most resilient and innovative sectors. This massive industry encompasses everything from high-growth biotech startups found on our Complete Biotech List to established Pharma Companies like Eli Lilly. In 2026, the sector is being reshaped by the rapid adoption of GLP-1 weight-loss drugs and AI-driven medical diagnostics. Whether you are looking for defensive health plans or surgical innovators in Medical Devices, this hub provides the data density needed to benchmark the industry's leaders.
Key Takeaways
01
Mega-Cap Dominance
A handful of firms like Eli Lilly (LLY) and UnitedHealth (UNH) account for nearly half of the sector's top 10 market capitalization.
02
GLP-1 Growth Engine
Pharmaceutical leaders are currently driven by breakthroughs in metabolic health, with Eli Lilly leading the 2026 rankings in total valuation.
03
Biotech IPO Recovery
The IPO market for healthcare has seen a resurgence, with 22 major biotech listings raising over $3.27B, focusing on gene therapy and AI.
04
Device Innovation
Companies specializing in robotic surgery and advanced diagnostics continue to see high demand. Check our Medical Devices list for details.
Top complete list of health care companies by Market Cap (2026)
The following table tracks the ten largest healthcare entities by market capitalization currently listed on U.S. exchanges as of early Q2 2026.
| Rank | Ticker | Company | Subsector | Market Cap | YTD % | P/E Ratio | Div Yield |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly | Pharma | $968B | +16.2% | 114.2 | 0.54% |
| 2 | JNJ | Johnson & Johnson | Diversified | $499B | +1.8% | 21.4 | 3.02% |
| 3 | ABBV | AbbVie | Pharma | $405B | +5.4% | 65.1 | 3.21% |
| 4 | MRK | Merck & Co. | Pharma | $342B | +3.1% | 195.4 | 2.31% |
| 5 | UNH | UnitedHealth Group | Health Plans | $304B | -2.5% | 18.3 | 1.45% |
| 6 | ISRG | Intuitive Surgical | Medical Devices | $182B | +12.0% | 82.4 | -- |
| 7 | TMO | Thermo Fisher | Tools/Diagnostics | $215B | +4.3% | 35.1 | 0.25% |
| 8 | AMGN | Amgen | Biotech | $168B | +2.1% | 22.4 | 3.05% |
| 9 | VRTX | Vertex Pharma | Biotech | $115B | +6.7% | 28.3 | -- |
| 10 | PFE | Pfizer | Pharma | $156B | -0.5% | -- | 5.82% |
Market data is approximate and for informational purposes only. Data reflects early Q2 2026 figures. Not a recommendation to buy or sell.
complete list of health care companies — Complete Company List
Healthcare Stocks
A list of publicly traded healthcare companies, healthcare ETFs and recent healthcare IPOs can be found by scrolling down or you can access a list of the companies in each group through the industry links on this page.
Large-Cap Stocks
Mid-Cap Stocks
Small-Cap Stocks
Micro-Cap Stocks
Nano-Cap Stocks
Specific/Classes of Diseases
Areas of the Body
- Blood
- Central Nervous System
- Dental
- Ears
- ENT
- Eye Care
- Gastrointestinal
- Heart
- Kidney
- Liver
- Respiratory Health
- Skin Care
- Spine
- Urology
- Vascular
Specific Demographics
- Animal Health
- Children
- Women’s Health
- Aesthetics
- Pain Management
- Sleep
- Weight Loss
- Wound Care
- Diagnostics
- AmerisourceBergen Corporation (Holding Co) (ABC)
- Cardinal Health, Inc. (CAH)
- Henry Schein, Inc. (HSIC)
- McKesson Corporation (MCK)
Medical Software
Biotech
- Biotech
- Large-Cap Biotech Stocks
- Mid-Cap Biotech Stocks
- Small-Cap Biotech Stocks
- Micro-Cap Biotech Stocks
Pharmaceuticals
- Pharmaceuticals
- Large-Cap Pharmaceuticals
- Mid-Cap Pharmaceuticals
- Small-Cap Pharmaceuticals
- Micro-Cap Pharmaceuticals
Medical Equipment
- Medical Device Companies
- Large-Cap Medical Device Companies
- Mid-Cap Medical Device Companies
- Small-Cap Medical Device Companies
Healthcare Facilities
- Large-Cap Healthcare Facilities
- Mid-Cap Healthcare Facilities
- Small-Cap Healthcare Facilities
- Micro-Cap Healthcare Facilities
- Ambulatory Surgery Centers
- Behavioral Healthcare
- Home Health Care
- Hospice Care
- Hospitals
- Laboratories
- Medical Clinics
- Medical Groups
- Medical REITs
- Memory Care
- Nursing Facilities
- Physician Practices
- Rehabilitation and Physical Therapy
- Senior Living
- Surgery Centers
- Urgent Care
Diagnostics
Healthcare Categories
- Anesthesia
- Antibodies
- Consumer Healthcare Products
- Drug Delivery
- Drug Stores
- Gene Therapy
- Generic Drug Companies
- Healthcare Distributors
- Healthcare Research Services
- Healthcare Services
- Healthcare Websites
- Medical Imaging
- Medical Robotics
- Medical Software
- Prosthetics
- Radiology
- Regenerative Medicine
- Vaccines
Healthcare Areas of Focus
- Aesthetics
- Animal Health
- Blood
- Cancer
- Central Nervous System
- Dental
- Diabetes
- Ears and Hearing Loss
- Ear Nose and Throat
- Eye Care
- Gastrointestinal
- Heart
- Infectious Diseases
- Kidney
- Liver
- Multiple Sclerosis
- Neurological
- Pain Management
- Prenatal and Children
- Orthopedics
- Rare Diseases
- Respiratory Health
- Skin Care
- Sleep
- Spine
- Urology
- Vascular
- Weight Loss
- Women’s Health
- Wound Care
Healthcare Comparison Widgets
- Large-Cap Healthcare Sector Comparison Widget
- Mid-Cap Healthcare Sector Comparison Widget
- Small-Cap Healthcare Sector Comparison Widget
- Micro-Cap Healthcare Sector Industry Comparison Widget
- Nano-Cap Healthcare Sector Comparison Widget
- Aesthetics Industry Comparison Widget
- Animal Health Industry Comparison Widget
- Blood Related Companies Industry Comparison Widget
- Central Nervous System Industry Comparison Widget
- Consumer Health Products Industry Comparison Widget
- Dental Industry Comparison Widget
- Dermatology Industry Comparison Widget
- Diabetes Industry Comparison Widget
- Diagnostics Industry Comparison Widget
- Drug and Alcohol Testing Industry Comparison Widget
- Drug Delivery Industry Comparison Widget
- Drug Store Industry Comparison Widget
- Ear and Hearing Loss Industry Comparison Widget
- Gastrointestinal Disorders Industry Comparison Widget
- Generic Drug Industry Comparison Widget
- Healthcare Distributors Industry Comparison Widget
- Healthcare Research Service Industry Comparison Widget
- Healthcare Services Industry Comparison Widget
- Heart and Cardiovascular Industry Comparison Widget
- Infectious Disease Industry Comparison Widget
- Kidney and Dialysis Industry Comparison Widget
- Liver Treatment Industry Comparison Widget
- Medical Software Industry Comparison Widget
- Molecular Diagnostics Industry Comparison Widget
- Multiple Sclerosis Industry Comparison Widget
- Neurological Disorder Industry Comparison Widget
- Ophthalmology Industry Comparison Widget
- Orthopedic Industry Comparison Widget
- Pain Management Industry Comparison Widget
- Prenatal, Newborn and Children Healthcare Industry Comparison Widget
- Rare and Orphan Disease Industry Comparison Widget
- Respiratory Health Industry Comparison Widget
- Sleep Industry Comparison Widget
- Spinal Industry Comparison Widget
- Urological Industry Comparison Widget
- Vaccine Industry Comparison Widget
- Vascular Disease Industry Comparison Widget
- Weight Loss and Obesity Industry Comparison Widget
- Women’s Healthcare Industry Comparison Widget
- Wound Care Industry Comparison Widget
Health Care Sector ETFs
- Fidelity MSCI Health Care Index ETF (FHLC)
- First Trust Health Care AlphaDEX ETF (FXH)
- Guggenheim S&P 500 Equal Weight Health Care ETF (RYH) (Holdings are equally weighed)
- Health Care Select Sector SPDR Fund (XLV)
- iShares U.S. Healthcare ETF (IYH)
- PowerShares DWA Healthcare Momentum Portfolio (PTH) (Companies demonstrating relative strength)
- Vanguard Health Care Index Fund (VHT)
Health Care ETFs: Medical Devices
Health Care ETFs: Small-Cap Companies
Health Care ETFs: Equipment
Health Care ETFs: Services
Health Care ETFs: Leveraged
- ProShares Ultra Health Care (RXL) (Daily Target 2x)
Health Care ETFs: Short
- ProShares UltraShort Health Care (RXD) (Daily Target -2x)
Health Care ETFs
- iShares Global Healthcare ETF (IXJ) (United States companies included)
- SPDR S&P International Health Care Sector ETF (IRY) (Weighted towards pharmaceutical companies; United States companies excluded)
Other Global Health Care ETFs
Additional healthcare focused companies can be found in the following sections
- List of Biotech Companies
- List of Healthcare Facilities
- List of Pharmaceutical Companies
- List of Medical Device Companies
Healthcare
- Abaxis, Inc. (ABAX) (Point-of-care blood analyzers for humans and animals)
- Accelerate Diagnostics, Inc. (AXDX) (Tests for infectious pathogens)
- Akers Biosciences Inc. (AKER) (Point-of-care screening and testing products)
- Allscripts Healthcare Solutions, Inc. (MDRX) (Healthcare information technology: practice management and electronic health records; patient engagement and care coordination; data analytics)
- AmerisourceBergen Corporation (Holding Co) (ABC) (Pharmaceutical sourcing and distribution)
- AMN Healthcare Services Inc. (AHS) (Healthcare staffing and workforce services)
- athenahealth, Inc. (ATHN) (Cloud-based business services for medical practices and health systems; examples include clinical, patient, referral and revenue cycle management)
- Avid Bioservices, Inc. (CDMO) (Contract development and manufacturing organization)
- Bioanalytical Systems, Inc. (BASI) (Contract research services and niche instrumentation)
- Biocept, Inc. (BIOC) (Molecular oncology)
- Biomerica, Inc. (BMRA) (Medical diagnostic products)
- BioScrip, Inc. (BIOS) (Health and beauty products, vitamins, home healthcare supplies, prescriptions)
- BioTelemetry, Inc. (BEAT) (Cardiac monitoring devices, cardiac monitoring services, cardiac laboratory services)
- Cancer Genetics, Inc. (CGIX) (DNA-based diagnostics)
- Cardinal Health, Inc. (CAH) (Drug and healthcare product distribution, consumer healthcare products, direct-to-home medical supplies distributor)
- CareDx, Inc. (CDNA) (Diagnostics for use in the surveillance of organ transplant patients)
- Castlight Health, Inc. (CSLT) (Cloud-based healthcare software for health care)
- Cerner Corporation (CERN) (Healthcare information technology: cloud-based platform; clinical, financial and management information systems)
- Charles River Laboratories International, Inc. (CRL) (Basic research, clinical support, discovery, process manufacturing and safety and efficacy)
- Check-Cap Ltd. (CHEK) (IPO in January 2015, Israel: Ingestible imaging capsule for the screening for colorectal cancer)
- Chembio Diagnostics, Inc. (CEMI) (Tests for infectious diseases)
- China Jo-Jo Drugstores, Inc. (CJJD) (China: retail drugstores; wholesale distributor of pharmaceutical and healthcare products)
- China Nepstar Chain Drugstore Ltd. (NPD) (China: retail drugstore chain)
- Co-Diagnostics, Inc. (CODX) (IPO July 12, 2017; molecular diagnostics)
- Computer Programs and Systems, Inc. (CPSI) (Electronic health record systems; business, consulting and managed IT services; target market includes rural and community hospitals)
- Concord Medical Services Holdings Limited (CCM) (China: Radiotherapy and diagnostic imaging centers)
- CorVel Corp. (CRVL) (Risk and healthcare management solutions)
- CRH Medical Corporation (CRHM) (Products and services for physicians)
- Cross Country Healthcare, Inc. (CCRN) (Healthcare staffing)
- CVS Health Corporation (CVS) (Nationwide drugstore chain, pharmacy benefit management services; retail medical clinics)
- CynergisTek Inc. (CTEK) (Document management and cybersecurity solutions to the healthcare industry)
- Danaher Corporation (DHR) (Diversified Conglomerate: Environmental, dental, diagnostics, life sciences, industrial technologies, test & measurement)
- Diplomat Pharmacy, Inc. (DPLO) (Independent specialty pharmacy)
- DLH Holdings Corp. (DLHC) (Healthcare and logistics services to the United States government)
- Evolent Health, Inc. (EVH) (IPO in June 2015: Integrated healthcare payment and delivery platform)
- EXACT Sciences Corporation (EXAS) (Molecular oncology)
- Express Scripts Holding Company (ESRX) (Pharmacy benefit management company: formulary management programs, retail drug card programs, home delivery services)
- Fulgent Genetics, Inc. (FLGT) (IPO September 29, 2016: genetic testing)
- Genetic Technologies Ltd. (GENE) (Molecular diagnostics: cancer management tests)
- GenMark Diagnostics, Inc. (GNMK) (Cystic fibrosis, respiratory viral)
- Genomic Health, Inc. (GHDX) (Molecular oncology)
- Healthcare Services Group, Inc. (HCSG) (Facility services)
- HealthEquity, Inc. (HQY) (Health savings accounts)
- HealthStream, Inc. (HSTM) (Software-as-a-service; workforce development, training & learning management, simulation-based training programs, performance assessment, credentialing, talent management)
- Henry Schein, Inc. (HSIC) (Health care products and services for animal health, dental and medical practitioner markets)
- Heska Corporation (HSKA) (Veterinary diagnostic and specialty veterinary products)
- HMS Holdings Corp (HMSY) (Provides services to the healthcare insurance benefit industry)
- HTG Molecular Diagnostics, Inc. (HTGM) (IPO in May 2015: molecular profiling)
- ICON Plc. (ICLR) (Ireland: outsourced development services)
- Inovalon Holdings, Inc. (INOV) (Cloud-based data analytics and data-driven intervention platforms)
- Interpace Diagnostics Group, Inc. (IDXG) (Diagnostics)
- Invitae Corporation (NVTA) (Genetic diagnostics for hereditary disorders)
- IQVIA Holdings, Inc. (IQV)
- ITUS Corporation (ITUS) (Diagnostics)
- Lantheus Holdings, Inc. (LNTH) (IPO in June 2015: Diagnostic medical imaging agents; heart failure, coronary artery disease, peripheral vascular disease, strokes)
- Magellan Health, Inc. (MGLN) (Specialty health care manager)
- McKesson Corporation (MCK) (Pharmaceutical distributor; software; automation technology; business services and consulting; Health Mart retail pharmacy franchisees)
- Medpace Holdings, Inc. (MEDP) (IPO August 11, 2016: clinical contract research organization)
- Medical Transcription Billing, Corp. (MTBC) (Software-as-a-service platform: WebEHR, revenue cycle, practice management, data management, business services)
- Medidata Solutions, Inc. (MDSO) (Cloud-based solutions for clinical research in life sciences)
- Meridian Bioscience Inc. (VIVO) (Tests for respiratory infections, parasitology, foodborne diseases)
- Myriad Genetics, Inc. (MYGN) (Hereditary cancer, nephrology, autoimmune diseases, diabetes, neuropsychiatry)
- NantHealth, Inc. (NH) (IPO June 2, 2016: personalized healthcare company; healthcare data solutions)
- National Research Corporation (NRC) (Healthcare research and quality improvement services for health care providers)
- Natera Inc. (NTRA) (IPO in July 2015: Genetic testing and diagnostics company)
- Navidea Biopharmaceuticals, Inc. (NAVB) (Precision diagnostics, therapeutics and radiopharmaceutical agents)
- Neogen Corporation (NEOG) (Products dedicated to food and animal safety)
- Omnicell, Inc. (OMCL) (Automation and business information products: Central pharmacy automation, business analytics, medication management systems, medical administration, medical supply management systems)
- OncoCyte Corporation (OCX) (Liquid biopsy cancer diagnostic tests)
- OpGen, Inc. (OPGN) (IPO in May 2015: Diagnostics; molecular testing and bioinformatics)
- Opko Health Inc. (OPK) (Point-of-care diagnostics; molecular diagnostics, pharmaceuticals, vaccines)
- OraSure Technologies, Inc. (OSUR) (Point-of-care diagnostics and collection devices)
- Owens & Minor, Inc. (OMI) (Distribution of medical and surgical supplies)
- Oxford Immunotec Global Plc. (OXFD) (United Kingdom: immunology diagnostic company)
- Patterson Companies, Inc. (PDCO) (Specialty distributor: dental and veterinary)
- PetIQ, Inc. (PETQ) (IPO July 21, 2017; pet medication manufacturer and distributor)
- PetMed Express, Inc. (PETS) (Online Pet Pharmacy)
- PRA Health Sciences, Inc. (PRAH) (Contract research services)
- Premier, Inc. (PINC) (Member-owned alliance of hospitals and healthcare providers)
- Prestige Brand Holdings, Inc. (PBH) (Brands include Chloraseptic, Clear Eyes, Compound W, Efferdent, Monistat, Luden’s, Nix and PediaCare)
- ProPhase Labs, Inc. (PRPH) (Over-the-counter cold remedy, consumer health products, natural base health products, supplements, cosmeceuticals)
- Psychemedics Corporation (PMD) (Testing services through hair samples)
- Quality Systems, Inc. (QSII) (Computer-based services: practice management, electronic health records, revenue cycle management, connectivity)
- Quanterix Corporation (QTRX) (IPO December 7, 2017; digital immunoassay platform)
- Quest Diagnostics Inc. (DGX) (Diagnostic testing services, diagnostic products, clinical trials testing, healthcare IT and wellness and risk management services)
- Quidel Corporation (QDEL) (Tests for infectious diseases, gastrointestinal diseases, women’s health)
- Quotient Limited (QTNT) (United Kingdom: diagnostic transfusion services)
- R1 RCM Inc. (RCM) (Revenue cycle management services)
- RadNet, Inc. (RDNT) (Fixed-site diagnostic imaging services through it’s over 250 outpatient imaging centers)
- Rite Aid Corporation (RAD) (Retail drugstore locations in over 30 states)
- Simulations Plus, Inc. (SLP) (Modeling and simulation software used by the pharmaceutical and biotechnology industries)
- Streamline Health Solutions, Inc. (STRM) (Computer software-based services: coding and clinical documentation, financial management, patient engagement, patient care, health information management)
- SurModics, Inc. (SRDX) (Two core businesses: in vitro diagnostics and medical device coatings)
- Syneos Health (SYNH) (Contract Research Organization and Contract Commercial Organization)
- T2 Biosystems, Inc. (TTOO) (Test for sepsis, hemostasis, lyme disease)
- Teladoc Inc. (TDOC) (IPO in July 2015: Telehealth provider)
- Trinity Biotech Plc. (TRIB) (Ireland: tests for autoimmune disorders, cardiac arrest, diabetes, infectious diseases, sexually transmitted diseases)
- United-Guardian, Inc. (UG) (Healthcare and personal care products)
- Veeva Systems Inc. (VEEV) (Cloud-based software solutions for pharmaceutical and other life sciences companies)
- Veracyte, Inc. (VCYT) (Molecular cytology)
- Vermillion, Inc. (VRML) (Diagnostics used to detect and improve the treatment of gynecologic disease in women)
- VolitionRX Limited (VNRX) (Singapore: diagnostic tests for cancer and other diseases)
- Walgreens Boots Alliance, Inc. (WBA) (Retail drugstores throughout the United States and numerous other countries; wholesale and distribution)
Risks & Considerations
Regulatory & Pricing Risk
Healthcare companies are subject to intense scrutiny regarding drug pricing and government reimbursement rates, which can impact margins overnight.
Clinical Trial Failure
Biotech and pharma stocks face significant volatility tied to FDA approval processes. A single negative trial result can lead to massive market cap erosion.
Patent Cliff Exposure
Many mega-cap pharmaceutical firms face upcoming patent expirations on blockbuster drugs, creating revenue gaps that must be filled by new pipelines.
Geopolitical Supply Chains
Dependence on international manufacturing for active pharmaceutical ingredients (APIs) poses a risk to supply chain stability and operational costs.
These risk factors are for educational purposes only and are not exhaustive. Individual investment decisions should be based on thorough due diligence.
Frequently Asked Questions
As of 2026, Eli Lilly (LLY) leads with a market cap of approximately $968B, followed by Johnson & Johnson (JNJ) at $499B and AbbVie (ABBV) at $405B. UnitedHealth Group (UNH) remains the largest health plan provider at $304B.
The market is dominated by U.S. giants including LLY, JNJ, ABBV, UNH, and Merck (MRK). These companies span multiple sectors including pharmaceuticals, medical devices, and health insurance plans.
There are over 1,000 healthcare companies listed on the NYSE and Nasdaq. This includes roughly 500 biotechnology firms and over 100 medical facility operators, along with device makers and distributors.
Vertex Pharmaceuticals (VRTX) at $115B and Amgen (AMGN) at $168B are among the leaders. The Nasdaq Biotechnology Index tracks the majority of these innovative firms.
Analysts currently highlight Eli Lilly (LLY) for its GLP-1 leadership and undervalued picks like Zoetis (ZTS) and Veeva Systems (VEEV) for long-term growth potential.
Approximately 1,063 healthcare-related companies are currently listed on major U.S. exchanges, ranging from mega-cap diversified giants to micro-cap clinical research firms.
The total U.S. healthcare sector is valued at approximately $7-8 trillion. The top 10 companies alone represent a significant portion of this, totaling over $3.5 trillion in value.
The IPO market has recovered in 2024 and 2025, with 22 biotech IPOs raising over $3.27 billion. 2026 trends show a heavy focus on gene editing and AI-integrated diagnostic technologies.
Last updated April 2026 · Data sourced from U.S. exchange filings